Kiniksa Pharmaceuticals International Plc (KNSA)
42.60
+0.87
(+2.08%)
USD |
NASDAQ |
Jan 09, 16:00
42.60
0.00 (0.00%)
After-Hours: 17:14
Kiniksa Pharmaceuticals International Profit Margin (Quarterly): 10.19% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| ADMA Biologics, Inc. | 27.14% |
| NovoCure Ltd. | -22.29% |
| LivaNova Plc | 7.49% |
| Marker Therapeutics, Inc. | -162.1% |
| Akanda Corp. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 7.60% |
| Return on Assets | 5.78% |
| Return on Invested Capital | 7.44% |
| Gross Profit Margin (Quarterly) | 53.78% |
| Operating Margin (Quarterly) | 13.28% |
| Return on Net Operating Assets | 36.36% |